Skip to main content

What the FDA labels say about taking them together

Amiodarone and nevirapine

Nevirapine's FDA label of July 15, 2026 names amiodarone in its drug interactions section; the amiodarone labels PlainMeds reads (2) do not name nevirapine. The nevirapine label: “Antiarrhythmics: Amiodarone, disopyramide, lidocaine Plasma concentrations may be decreased.”

Check it at the source: the amiodarone FDA label on DailyMed (effective December 9, 2025, Chartwell RX, LLC); the nevirapine FDA label on DailyMed (effective July 15, 2026, Mylan Pharmaceuticals Inc.).

What does the amiodarone label say about nevirapine?

Amiodarone's label (effective December 9, 2025) and its 1 other brand-application label do not name nevirapine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Amiodarone Hydrochloride), Chartwell RX, LLC, effective December 9, 2025 (SPL set 5520f11d-968d-4f4f-bf57-d14369c0d746), via openFDA; the full label on DailyMed

What does the nevirapine label say about amiodarone?

Nevirapine label, drug interactions

Antiarrhythmics: Amiodarone, disopyramide, lidocaine Plasma concentrations may be decreased.

Source: FDA drug label (Nevirapine), Mylan Pharmaceuticals Inc., effective July 15, 2026 (SPL set c6e93829-7024-48f6-8023-da6ff27dfc0a), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

32Amiodarone generic labelers
6Nevirapine generic labelers
AmiodaroneNevirapine
Labeled forn/aHIV
Boxed warningYesYes
Pharmacy cost (NADAC)$0.122 per tablet 200 mg tablet$0.147 per tablet 200 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?